Russia says search for a coronavirus treatment should not be a medical 'arms race'Russia's sovereign wealth fund (RDIF) has been funding Russian trials of the drug favipiravir, an anti-influenza drug first developed in Japan.[Collection]

Russia's sovereign wealth fund (RDIF) has been funding Russian trials of the drug favipiravir, an anti-influenza drug first developed in Japan.https://www.cnbc.com/2020/05/14/russia-coronavirus-treatment-favipiravir-showing-promising-results.html